2024's Most Influential Drug and Vaccine Approvals So Far

2024's Most Influential Drug and Vaccine Approvals So Far - GoodRx

Many medications have been approved so far in 2024 — and more are on deck. Here's a summary of 16 of the most notable approvals.

Novel Drug Approvals for 2024 - FDA

FDA Novel Drug Therapy Approvals for 2024 ; 12. Lumisight, pegulicianine, 4/17/2024, To use as an optical imaging agent for the detection of cancerous tissue ; 11 ...

Top 10 most anticipated drug launches of 2024 - Fierce Pharma

You'd be forgiven for scratching your head at what Evaluate believes will be the biggest drug launch of 2024, in terms of sales potential by ...

In the Pipeline: Top Drug Candidates for FDA Approval in 2024

These included Eli Lilly's expanded approval of Mounjaro in obesity (approved as Zepbound), CRISPR Therapeutics' gene editing treatment for ...

Updated 2024-2025 COVID Vaccines Approved: What To Know

The FDA approved new COVID-19 vaccines from Pfizer and Moderna on Thursday ahead of the 2024-2025 fall and winter respiratory virus season.

What to Know About the Updated 2024-2025 COVID Vaccines

Pfizer's and Moderna's updated mRNA vaccines were fully approved in the middle of August for everyone ages 12 and older, and each has a Food and ...

5 Key Potential Approvals for 2024 - Pharmacy Times

RSVpreF is also approved as a maternal RSV vaccine. Moderna's RSV vaccine (mRNA-1345) could join those as an additional option, with a PDUFA ...

Use of COVID-19 Vaccines for Persons Aged ≥6 Months - CDC

What is already known about this topic? The 2023–2024 COVID-19 vaccines provided protection against SARS-CoV-2 XBB-sublineage strains; however, ...

Top 5 Most Promising FDA New Drug Approvals Expected in ... - Xtalks

Some treatments already on the market have grabbed additional approvals in 2024, including Novo Nordisk's Wegovy (semaglutide) for ...

What you need to know about the 2024-25 COVID-19 vaccine ...

This week, the U.S. Food and Drug Administration (FDA) approved and granted emergency use authorization for updated mRNA COVID-19 vaccines. The ...

Updated 2024–2025 COVID-19 vaccines: who should get them ...

The Food and Drug Administration (FDA) in late August authorized and approved ... vaccine, as well as the updated protein-based Novavax vaccine.

FDA new drug approvals in Q2 2024 - Nature

The second quarter of 2024 picked up where Q1 left off, with a relatively muted 11 novel drug approvals (Table 1) to add to the tally of 10 approvals between ...

Azurity Wins FDA Approval for Oral CML Drug - BioSpace

In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as BioSpace keeps you up to date on all of the FDA's decisions in 2024.

FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines ...

FDA approved and authorized for emergency use updated mRNA COVID-19 vaccines (2024-2025 formula) to more closely target currently ...

Moderna Receives U.S. FDA Approval for Updated COVID-19 ...

CAMBRIDGE, MA / ACCESSWIRE / AUGUST 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced the U.S. Food and Drug Administration (FDA) has ...

Staying Up to Date with COVID-19 Vaccines - CDC

1 dose of the 2024–2025 Pfizer-BioNTech COVID-19 vaccine. People ages 12 years and older. You are up to date when you have received: 1 dose of ...

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 ...

1.5-adapted monovalent COVID-19 vaccine. This season's vaccine is indicated as a single dose for most individuals 5 years of age and older. Children under the ...

Comparing the COVID-19 Vaccines: How Are They Different?

The Pfizer-BioNTech vaccine (brand name: Comirnaty) was granted full Food and Drug Administration (FDA) approval in August 2021 for people ages ...

Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized ...

Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) has not been approved or licensed by the FDA but has been authorized for emergency use ...

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 ...

1.5-adapted monovalent COVID-19 vaccine. This season's vaccine is indicated as a single dose for most individuals 5 years of age and older.